Pharma & Biotech

Reviva Pharmaceuticals Holdings Inc. witnessed a sharp decline in its share price after unveiling plans to raise $9 million through...

Syndax Pharmaceuticals stands at a pivotal juncture, with a significant regulatory decision for its flagship cancer therapy scheduled for late...

Shares of Viking Therapeutics experienced substantial gains following the release of impressive Phase 2 trial results for its oral formulation...

Altimmune finds itself navigating turbulent waters as multiple class-action lawsuits cast a shadow over the company's stock performance. The litigation...

Pulse Biosciences, a prominent biotechnology firm, experienced significant volatility as a wave of insider selling activity followed a period of...

Neogenomics shares are experiencing significant turbulence as the company navigates disappointing quarterly results, intensifying competitive pressures, and a major patent...

Arrowhead Pharmaceuticals has emerged as a compelling story within the biotechnology sector, capturing significant investor attention. The recent substantial appreciation...

The German biotechnology firm BioNTech, once a star performer during the pandemic, is facing significant market pressure. A wave of...

Eli Lilly finds itself navigating regulatory challenges as the U.S. Food and Drug Administration takes issue with the pharmaceutical giant's...

Bayer's preferred shares (BAYN.DE) demonstrated modest resilience in Thursday's trading session, closing at $8.08 with a slight gain of 0.12%....